37 (3), E124
Understanding your options helps you work with your surgeon to create a comprehensive treatment plan that addresses all areas of concern while managing surgical risks and recovery time
As summarized in Table 1 , renal eligibility criteria across landmark GLP-1 RA cardiovascular and kidney outcome trials consistently excluded dialysis-dependent patients, resulting in a persistent lack of randomized evidence in this high-risk population
When this hormone binds to receptors in the brain, pancreas, stomach, and elsewhere, several things happen: Appetite is significantly reduced, with many patients reporting a dramatic decrease in food cravings Gastric emptying slows, meaning food stays in the stomach longer and fullness is sustained after smaller meals Blood sugar regulation improves, reducing the energy spikes and dips that typically drive overeating Interest in high-calorie and highly processed foods often reduces, an effect many patients describe as the food noise quietening Mounjaro (tirzepatide) adds a second mechanism by also activating the GIP receptor
TRIUMPH-4 reported that participants receiving retatrutide 12mg achieved an average of 28.7% body weight reduction at 68 weeks among the highest documented in any obesity pharmacotherapy trial